About                                                                                                                          

Biopharmix Consulting offers the comprehensive capabilities and deep industry knowledge necessary to help you solve the most complex issues of your organization. With biotech experience ranging from genomics research, clinical data management, and clinical trial data and sales support, we are ready to support our clients quarterly campaign or ongoing projects with expertise. Since opening our doors in 2012, we’re proud to say that each year we have a growing list of returning and new clients.





TESTIMONIALS

Territory Expansion

“Rhonda’s skills at territory research, lead qualifying and initial communications made a valuable contribution to our sales expansion into the Midwest, and of our marketing expansion into toxicology. Her scientific background enabled her to quickly identify the quality leads and her extensive biotech network was an asset as well. Rhonda also supplied a trade show presence at AAPS and delivered effective presentations on our behalf. I would recommend Rhonda’s services to any biopharma services firm needing a better market footprint.”
-Carol G., BD Manager, OncoDesign


Transporter Assay Sales

“Biopharmix has been expanding Optivia's sales territories in the US and world-wide since September 2012. In the Midwest territory where Rhonda managed accounts, responses to her initial inquiries are notably high and as a result she’s opened new doors for Optivia. Her contributions to our overall marketing and sales strategies show her expertise in both drug discovery and sales.”
-Dawn S., Director of BD, BioIVT


Internationalization

“Rhonda produced the Japanese version of a website from my translation and specifications. Without knowing the language, she was able to incorporate formatting and hyperlinks for the kanji characters without error. Even our English-speaking Japanese clients appreciate this internationalization. I highly recommend Rhonda for world-wide territory expansion this way.”
-Ruaori M., Managing Director, CBO, Eolas Biosciences Co.